Matches in SemOpenAlex for { <https://semopenalex.org/work/W2031239842> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2031239842 endingPage "62" @default.
- W2031239842 startingPage "62" @default.
- W2031239842 abstract "We report six patients with progressive primary tumors of the brain who had prolonged periods with stable contrast-enhancing CT lesions following initial responses to chemotherapy. Chemotherapy was discontinued after 21 to 36 months, despite the persistence of apparent disease in each patient. PET using (F-18) fluorodeoxyglucose was performed in three patients, revealing hypometabolic lesions. All six patients are alive and well, with no clinical or radiographic evidence of progressive disease at 24 to 57+ months following termination of treatment. The usual criteria for terminating phase II chemotherapy in patients with a recurrent brain tumor are evidence of progressive disease or unacceptable toxicity. However, chemotherapeutic success mandates that these criteria be expanded to include patients whose response following the initiation of phase II treatment is followed by prolonged (greater than 1 year) radiographic and clinical stability. Complete response, ie, disappearance of all evidence of disease, is unusual in patients with recurrent primary brain tumors, even with highly effective therapy. Continued improvement in the therapy of patients with these tumors will allow wider application of these criteria." @default.
- W2031239842 created "2016-06-24" @default.
- W2031239842 creator A5002198081 @default.
- W2031239842 creator A5002449505 @default.
- W2031239842 creator A5007074423 @default.
- W2031239842 creator A5010640420 @default.
- W2031239842 creator A5042596874 @default.
- W2031239842 creator A5049201881 @default.
- W2031239842 creator A5051980635 @default.
- W2031239842 creator A5057593223 @default.
- W2031239842 creator A5060384074 @default.
- W2031239842 date "1989-01-01" @default.
- W2031239842 modified "2023-09-27" @default.
- W2031239842 title "Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor" @default.
- W2031239842 doi "https://doi.org/10.1212/wnl.39.1.62" @default.
- W2031239842 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2783351" @default.
- W2031239842 hasPublicationYear "1989" @default.
- W2031239842 type Work @default.
- W2031239842 sameAs 2031239842 @default.
- W2031239842 citedByCount "10" @default.
- W2031239842 countsByYear W20312398422012 @default.
- W2031239842 crossrefType "journal-article" @default.
- W2031239842 hasAuthorship W2031239842A5002198081 @default.
- W2031239842 hasAuthorship W2031239842A5002449505 @default.
- W2031239842 hasAuthorship W2031239842A5007074423 @default.
- W2031239842 hasAuthorship W2031239842A5010640420 @default.
- W2031239842 hasAuthorship W2031239842A5042596874 @default.
- W2031239842 hasAuthorship W2031239842A5049201881 @default.
- W2031239842 hasAuthorship W2031239842A5051980635 @default.
- W2031239842 hasAuthorship W2031239842A5057593223 @default.
- W2031239842 hasAuthorship W2031239842A5060384074 @default.
- W2031239842 hasConcept C126322002 @default.
- W2031239842 hasConcept C126838900 @default.
- W2031239842 hasConcept C141071460 @default.
- W2031239842 hasConcept C142724271 @default.
- W2031239842 hasConcept C2776694085 @default.
- W2031239842 hasConcept C2778822529 @default.
- W2031239842 hasConcept C2779130545 @default.
- W2031239842 hasConcept C2779134260 @default.
- W2031239842 hasConcept C2779281540 @default.
- W2031239842 hasConcept C36454342 @default.
- W2031239842 hasConcept C509974204 @default.
- W2031239842 hasConcept C71924100 @default.
- W2031239842 hasConceptScore W2031239842C126322002 @default.
- W2031239842 hasConceptScore W2031239842C126838900 @default.
- W2031239842 hasConceptScore W2031239842C141071460 @default.
- W2031239842 hasConceptScore W2031239842C142724271 @default.
- W2031239842 hasConceptScore W2031239842C2776694085 @default.
- W2031239842 hasConceptScore W2031239842C2778822529 @default.
- W2031239842 hasConceptScore W2031239842C2779130545 @default.
- W2031239842 hasConceptScore W2031239842C2779134260 @default.
- W2031239842 hasConceptScore W2031239842C2779281540 @default.
- W2031239842 hasConceptScore W2031239842C36454342 @default.
- W2031239842 hasConceptScore W2031239842C509974204 @default.
- W2031239842 hasConceptScore W2031239842C71924100 @default.
- W2031239842 hasIssue "1" @default.
- W2031239842 hasLocation W20312398421 @default.
- W2031239842 hasLocation W20312398422 @default.
- W2031239842 hasOpenAccess W2031239842 @default.
- W2031239842 hasPrimaryLocation W20312398421 @default.
- W2031239842 hasRelatedWork W1946468667 @default.
- W2031239842 hasRelatedWork W2031239842 @default.
- W2031239842 hasRelatedWork W2047967234 @default.
- W2031239842 hasRelatedWork W2090815264 @default.
- W2031239842 hasRelatedWork W2335858412 @default.
- W2031239842 hasRelatedWork W2348633071 @default.
- W2031239842 hasRelatedWork W2376998325 @default.
- W2031239842 hasRelatedWork W2391281299 @default.
- W2031239842 hasRelatedWork W2439875401 @default.
- W2031239842 hasRelatedWork W2564517819 @default.
- W2031239842 hasVolume "39" @default.
- W2031239842 isParatext "false" @default.
- W2031239842 isRetracted "false" @default.
- W2031239842 magId "2031239842" @default.
- W2031239842 workType "article" @default.